POSTED ON Thursday, June 11th, 2020 IN CLIENT & ALUMNI NEWS
OraSure Technologies, Inc. received nearly $630,000 from a contract with the federal Biomedical Advanced Research and Development Authority to help develop an oral test for coronavirus antibodies. The test could help identify people who had a COVID-19 infection, even without symptoms, potentially allowing them to safely return to work or other activities if data show antibody development translates to future immunity. Via Lehigh Valley Business